GlassScriptPhysician profile
Jordyn Platz
NPI 1548882814
$1,822.76
in general payments reported to CMS, 2019-2025
15 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.05 · 2022: $213 · 2023: $438 · 2024: $842 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $555.09 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $181.91 | 2024 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $145.38 | 2022-2024 | Entyvio |
| Madrigal Pharmaceuticals | $139.26 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $136.52 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.36 | 2023-2025 | Xifaxan |
| Qol Medical, LLC | $109.16 | 2022-2025 | Sucraid, Sucraid |
| Merck Sharp & Dohme LLC | $95.24 | 2022-2024 | Dificid |
| Lilly USA, LLC | $74.62 | 2024-2025 | Omvoh |
| Celgene Corporation | $74.39 | 2021-2024 | Zeposia |
| Genzyme Corporation | $54.30 | 2022-2025 | |
| Pfizer INC. | $44.79 | 2022-2024 | |
| Phathom Pharmaceuticals, INC. | $30.55 | 2024 | Voquezna |
| Glaxosmithkline, LLC. | $29.71 | 2022-2024 | Trelegy Ellipta |
| Ardelyx, INC. | $18.48 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordyn Platz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.